Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Kimura, Junpei ^a   Ichii, Osamu ^a   Otsuka, Saori ^a   Kanazawa, Tomonori ^a   Namiki, Yuka ^a   Hashimoto, Yoshiharu ^a   Kon, Yasuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CXCL2 CHEMOKINE; INTERLEUKIN 1; INTERLEUKIN 10; MESSENGER RNA; ONCOPROTEIN; UNCLASSIFIED DRUG; WILMS TUMOR 1; BIOLOGICAL MARKER;

ALBUMIN URINE LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL; CELL COUNT; CELL DAMAGE; CELL LOSS; CELL TYPE; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; EPITHELIUM CELL; GLOMERULONEPHRITIS; HISTOPATHOLOGY; KIDNEY DISTAL TUBULE; MALE; MOUSE; NEPHRON; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; URINARY CELL; URINE LEVEL; ANIMAL; C57BL MOUSE; KIDNEY DISEASE; PATHOLOGY; URINE;

MURINAE; MUS;

ANIMALS; BIOLOGICAL MARKERS; CELL COUNT; EPITHELIAL CELLS; GLOMERULONEPHRITIS; KIDNEY DISEASES; KIDNEY TUBULES, DISTAL; MICE; MICE, INBRED C57BL; PODOCYTES; URINE;

EID: 79551651126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016472     Document Type: Article

References (44)

1. Lysaght MJ (2002) Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 13: 37-40.
2. Nakai S, Wada A, Kitaoka T, Shinzato T, Nagura Y, et al. (2008) An overview of regular dialysis treatment in Japan as of Dec. 31, 2006. Ther Apher Dial 12: 428-456.
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, et al. (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42: 1050-1065.
4. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, et al. (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17: 2034-2047.
5. Kriz W, LeHir M (2005) Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67: 404-419.
6. Kovesdy CP, Kalantar-Zadeh K (2009) Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology 14: 408-415.
7. Skoberne A, Konieczny A, Schiffer M (2009) Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Renal Physiol 296: 230-241.
8. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, et al. (2002) Podocyte number in normotensive type I diabetic patients with albuminuria. Diabetes 51: 3083-3089.
9. Wiggins R (2007) The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205-1214.
10. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, et al. (2001) Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968.
11. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, et al. (2005) Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952.
12. Matsusaka T, Xin J, Niwa S, Kobayashi K, Akatsuka A, et al. (2005) Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol 16: 1013-1023.
13. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, et al. (2003) Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 52: 1031-1035.
14. Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, et al. (1998) Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18: 35-41.
15. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, et al. (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15: 1379-1383.
16. Hara M, Yanagihara T, Kihara I (2001) Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89: 342-347.
17. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, et al. (2005) Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol 16: 408-416.
18. Hara M, Yanagihara T, Kihara I (2007) Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein- Henoch purpura nephritis. Clin J Am Soc Nephrol 2: 231-238.
19. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, et al. (2009) Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 20: 1041-1052.
20. Ichii O, Otsuka S, Sasaki N, Yabuki A, Ohta H, et al. (2010) Local overexpression of interleukin-1 family, member 6 relates to the development of tubulointerstitial lesions. Lab Invest 90: 459-475.
21. Ichii O, Konno A, Sasaki N, Endoh D, Hashimoto Y, et al. (2009) Onset of autoimmune glomerulonephritis derived from the telomeric region of MRLchromosome 1 is associated with the male sex hormone in mice. Lupus 18: 491-500.
22. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, et al. (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148: 1198-1215.
23. Ichii O, Konno A, Sasaki N, Endoh D, Hashimoto Y, et al. (2008) Autoimmune glomerulonephritis induced in congenic mouse strain carrying telomeric region of chromosome 1 derived from MRL/MpJ. Histol Histopathol 23: 411-422.
24. Schöcklmann HO, Lang S, Sterzel RB (1999) Regulation of mesangial cell proliferation. Kidney Int 56: 1199-1207.
25. Galkina E, Ley K (2006) Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17: 368-377.
26. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
27. Catania JM, Chen G, Parrish AR (2007) Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292: 905-911.
28. Reiser J, von Gersdorff G, Simons M, Schwarz K, Faul C, et al. (2002) Novel concepts in understanding and management of glomerular proteinuria. Nephrol Dial Transplant 17: 951-955.
29. Ryan GB, Karnovsky MJ (1975) An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8: 219-232.
30. Finco DR, Duncan JR (1976) Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature. J Am Vet Med Assoc 168: 593-601.
31. Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, et al. (2005) Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta 361: 182-190.
32. Wang G, Lai FM, Tam LS, Li KM, Lai KB, et al. (2007) Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis. J Rheumatol 34: 2358-2364.
33. Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, et al. (2008) Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol 158: 317-322.
34. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, et al. (2002) Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61: 1475-1485.
35. Nakatsue T, Koike H, Han GD, Suzuki K, Miyauchi N, et al. (2005) Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int 67: 2239-2253.
36. Barksby HE, Lea SR, Preshaw PM, Taylor JJ (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149: 217-225.
37. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, et al. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350.
38. Sacks SH, Zhou W, Sheerin NS (1996) Complement synthesis in the injured kidney: does it have a role in immune complex glomerulonephritis? J Am Soc Nephrol 7: 2314-2319.
39. Brooimans RA, Stegmann AP, van Dorp WT, van der Ark AA, van der Woude FJ, et al. (1991) Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88: 379-384.
40. Ueki A, Sai T, Oka H, Tabata M, Hosokawa K, et al. (1987) Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology 61: 11-14.
41. Sheerin NS, Risley P, Abe K, Tang Z, Wong W, et al. (2008) Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J 22: 1065-1072.
42. Abe K, Li K, Sacks SH, Sheerin NS (2004) The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol 136: 60-66.
43. David S, Biancone L, Caserta C, Bussolati B, Cambi V, et al. (1997) Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 12: 51-56.
44. Tang Z, Lu B, Hatch E, Sacks SH, Sheerin NS (2009) C3a mediates epithelialto- mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol 20: 593-603.